If you live and breathe the beautiful game, how about moving to a property near to your team's grounds?
The pharma & biotech companies hire other companies to conduct the clinical trials, as the companies do not have the expertise, time, or infrastructure to carry out the clinical trials. Outsourcing clinical trials delivers advantages such as cost efficiency, minimum timeline, and best result delivery.
New York, Aug. 11, 2022 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Clinical Trials Outsourcing Market – Global Outlook & Forecast 2022-2027” – https://www.reportlinker.com/p06313595/?utm_source=GNW
Most clinical trials are outsourced to contract research organizations and third-party vendors.
Clinical trial outsourcing delivers significant advantages in terms of cost. Clinical drug development trials are vital, requiring higher expenditure and high-class infrastructure and expertise. Due to the complexity of clinical trial processes, sponsors constantly face pressure from regulatory agencies, insurers, and the medical community to reduce costs by increasing the size of development projects, their pipelines’ pipeline quality and safety of their products, and their compliance with regulatory requirements.
Most Biopharmaceutical companies spend their higher expenditure on research & development activities and clinical trials. In the end, lower chances of success rate impact the company’s growth largely; therefore, outsourcing easily reduces this complexity. Remote trials can reduce around 25% to 30% trials cost due to the services associated with patient travel and the number of staff required for monitoring on the site.
Impact of Covid-19 Pandemic
The Covid-19 pandemic gave an absolute massive shift and forced the clinical trial industries to look for outsourcing. Clinical trial complexity is a significant factor that drives clinical trial outsourcing. Robust pipelines and stringent regulations in clinical trials operate the clinical development services.
Virtual Clinical Trials: The Rising Market
Virtual clinical trials are a rapidly increasing trend in biopharma industries. It is one of the new clinical trial models, a highly underutilized method for conducting clinical trials and clinical research. Virtual clinical trials are cost-effective, time-saving, and easier for participants. Virtual collaboration strategies in clinical trials, using clinical trials software allows businesses to work rapidly and more efficiently, eliminates the need for document sharing to additional office locations, and reduces the burden.
KEY INDUSTRY INSIGHTS
• Downscaling the companies, managing the cost of the research, and reducing the expenditure has led to raised clinical trial outsourcing by the biopharmaceutical industry. The three significant factors, globalization, digitalization, and personalized medicines, highly impacted the clinical trials industries. These three major factors have positively influenced the clinical trial outsourcing market growth in recent years.
• Across the world, the rising patient population is one of the major problems for developed countries as their healthcare expenditure is increasing, so there is a demand for advanced treatments which provide value-based solutions to the patients. Biopharmaceutical companies constantly look for new drugs and derived clinical trial activities. Pharma Research and development outsourcing activities are significant in the industry, giving high potential for this market and related activities and triggering the demand for clinical trials outsourcing.
• AI in clinical trials is a revolutionizing technology primarily adopted among large CROs. In recent years AI application was rapidly explored during the COVID-19 pandemic period accelerating the clinical trials for a faster cure for the pandemic.
• The Indian biotech industry alone accounts for 2,700 start-ups, and the estimated number will increase to 10,000 by 2024. Globally, more than 2,093,000 pharma start-ups are running in the market; this rise in smaller companies will demand outsourcing clinical trials.
• Synthetic Data Improving Clinical Development minimizes or replaces the control arm of the clinical trial. It reduces the demand for patient recruitment, saves time and money, and eliminates the ethical issues regarding the placebo.
Usually, the pharma companies do not have access to real-world data. They majorly limit themselves within the clinical trials that they have conducted. This synthetic data, which is from real-world data, will help the companies to understand the real world and help them to find better solutions. Currently, there is an increase in single-arm clinical trials for rare diseases and oncology therapeutic areas. This has made it easy for people to work when comparing treatments. The entry of synthetic and external control arms has changed rapidly and growing significantly by enabling improved access to data, including statistical tool kits from various clinical research fields.
Segmentation by Application
• Cancer
• CVDs
• Infectious Diseases
• Infectious Diseases
• Musculoskeletal Diseases
• Nervous System Disorders
• Other Diseases
Segmentation by Clinical Trial Phase
• Phase I
• Phase II
• Phase III
• Phase IV
Segmentation by End-Users
• Small & Mid-Size Companies
• Large Size Companies
CLINICAL TRIALS OUTSOURCING MARKET TRENDS
• Implementing artificial intelligence (AI) in clinical trials is a revolutionizing technology, primarily adopted among large CROs. In recent years AI application was rapidly explored during the COVID-19 pandemic period accelerating the clinical trials for a faster cure for the pandemic. AI (Artificial Intelligence) helps make every clinical trial stage more efficient with design and patient recruitment and retention, followed by clinical trials outsourcing services by contract research organizations. It also allowed the companies to manage the extensive data without any errors and make decisions accordingly.
• Pharmaceutical and biotech companies are relying on research and development activities to develop new drugs. Rising expenditure on clinical research and development will deliver high market growth opportunities.
• An excellent opportunity for outsourcing clinical trials lies in rare diseases due to the limited patient population and rising prevalence of rare diseases globally. For outsourcing leaders, patient recruitment and retention are easy with the rising prevalence of rare diseases in low-middle companies. These CROs have an excellent partnership with government bodies and large healthcare providers to recruit patients. Most outsourcing companies are based in low-middle-income countries.
• The increasing demand for large molecules and personalized medicines such as cell and gene therapies have also helped drive the CRO outsourcing market consistently.
• An increasing number of small biopharma companies is one of the best clinical trial outsourcing market opportunities. The small and medium-sized biopharma companies account for a higher number of clinical research. Due to lower capital availability, lack of infrastructure, and expertise, small biopharma companies look towards outsourcing clinical trials.
INSIGHTS BY GEOGRAPHY
North America is the leading region in clinical trial outsourcing. But in recent years, clinical trial outsourcing shifting towards the emerging market. Emerging markets such as low-middle-income countries are the best geography for this market due to the high patient population and unaffordable pricing of new treatments or existing treatments in the LMICs.
On the other side, some emerging markets, such as BRICS (Brazil, Russia, India, China, and South Africa), have a better opportunity for clinical trials outsourcing market. These emerging geographies have a high potential for outsourcing trials. High patient pool demography is one of the strong reasons for outsourcing in those countries.
Segmentation by Geography
• APAC
o China
o Japan
o South Korea
o Australia
o India
• North America
o US
o Canada
• Europe
o Germany
o UK
o France
o Spain
• Latin America
o Brazil
o Mexico
• Middle East & Africa
o Saudi Arabia
o UAE
Key Vendors:
• Charles River Laboratories
• IQVIA
• ICON plc
• Labcorp Drug Development
• Syneos Health
• Thermo Fischer Scientific
• Wuxi AppTec
• Paraxel
Other Prominent Vendors
• Advanced Clinical
• Bioanalytix
• Curia Global
• CMED
• Cromos Pharma
• Criterium
• KCR SA.
• Medpace
• Medelis
• Oct Group
• Protrials Research
• Prometrika
• Quality Data Services
• QPS
• Sofpromed
• Veristat
• Worldwide Clinical Trials
KEY QUESTIONS ANSWERED
1. WHAT IS THE EXPECTED GROWTH OF THE CLINICAL TRIALS OUTSOURCING MARKET IN THE GLOBAL MARKET?
2. WHO ARE THE MAJOR PLAYERS IN THE CLINICAL TRIALS OUTSOURCING MARKET?
3. WHAT IS THE GROWTH RATE OF THE CLINICAL TRIALS OUTSOURCING MARKET?
4. HOW DOES COVID-19 IMPACT THE MARKET GROWTH OF CLINICAL TRIALS OUTSOURCING MARKET SHARE?
5. WHAT ARE THE FACTORS DRIVING THE CLINICAL TRIALS OUTSOURCING MARKET GROWTH?
Read the full report: https://www.reportlinker.com/p06313595/?utm_source=GNW
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.
__________________________
Top U.S. gas exporter, Freeport LNG, has retracted the force majeure it initially declared after an explosion in June, a development that could cost its buyers billions of dollars in losses, a document showed and three trading sources said. Force majeure is a notice used to describe events outside a company's control, such as a natural disaster, which usually releases it from contractual obligation without penalty. The force majeure would also have allowed Freeport’s LNG buyers to exit their own agreements to deliver gas to end users.
A squeeze in Russian gas supplies would threaten the credit ratings of Slovakia, the Czech Republic and Italy, Moody's said in a report on Thursday, while most of Europe would feel the economic effects of a likely spike in natural gas prices. Russian gas supplies to Europe at the beginning of August were about a third of their level before Russia's invasion of Ukraine, a shortfall only partially offset by higher imports of liquefied natural gas (LNG), the global ratings agency wrote. If Moscow were to halt all gas supplies, Slovakia and the Czech Republic could see their respective sovereign ratings of A2 and Aa3 jeopardised, Moody's said in its report.
ONS says two bank holidays to mark Queen’s jubilee contributed to fall in output in June
The PCS union is in dispute over a new courts case management system.
Treasury minister argues it is ‘absolutely right’ for the new leader to consider ‘these options in the round’ when they take the reins.
Global Gym Management Software Market Global Gym Management Software Market Dublin, Aug. 12, 2022 (GLOBE NEWSWIRE) — The "Global Gym Management Software Market (2022-2027) by Modules, Deployment, End-User, Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis" report has been added to ResearchAndMarkets.com's offering. The Global Gym Management Software Market is estimated to be USD 310.16 Bn in 2022 and is expected to reach USD 593.01 Bn by 2027, growing at a CAGR of
Global Application Programming Interface (API) Management Market Global Application Programming Interface (API) Management Market Dublin, Aug. 10, 2022 (GLOBE NEWSWIRE) — The "Global API Management Market by Component (Solutions and Services), Deployment Type (On-premises, Cloud), Organization Size (SMEs and Large Enterprises), Vertical (BFSI, IT & Telecom, and Retail & Consumer Goods) and Region – Forecast to 2027" report has been added to ResearchAndMarkets.com's offering. The API management
Guardian Australia picture editor Carly Earl explains the dos and don’ts of photographing the celestial spectacle, the last supermoon of of 2022
The red-hot property market has seen house prices soar in the last two years amid higher demand for more space during lockdowns.
Supervisory board of AS Harju Elekter elected Mr Priit Treial as the new member of the board and chief financial officer of the company, taking office on 14 November 2022 and his term of office is three years. Priit Treial has been a member of the board and chief financial officer of Elektrilevi OÜ since 2018, and a member of the council of Narva Soojus AS and Imatra Elekter AS since 2021. In 2016-2018, he worked as a financial controller at Eesti Energia AS. In addition, he has long-term work e
The estate agent group reported an 11% increase in its revenue in the first half of the year, bringing in £1.03 billion.
The ultimate “DAO operating system” solution for DAO creation and management, The Summon Platform, shows strong momentum since announcement three weeks ago. Next week, the platform’s crucial utility/governance token will be distributed to community members encouraging their active participation in development priorities.ZUG, Switzerland, Aug. 11, 2022 (GLOBE NEWSWIRE) — The Summon Platform, a comprehensive “operating system” for groups and organizations to easily create and manage Decentralized
iPhones must adopt new technologies to allow different phones to work better together, Android maker says
Families are being squeezed on all sides by surging mortgage, energy and food costs. Free products and services have rarely been so valuable in keeping household budgets under control – yet they are disappearing quickly.
The insurer has already dished out £4.75 billion to shareholders after selling off chunks of the business in recent years.
Potash and salt miner K+S reiterated its full-year profit guidance on Thursday, as it expects higher fertiliser prices to offset the impact of a potential gas shortage in Germany. This scenario assumes a 25% reduction in natural gas availability in the fourth quarter, which together with a new gas levy would lead to a cost burden in a low-triple-digit million euro range, CEO Burkhard Lohr said in a statement. For now, the company expects the gas shortage to only affect its final quarter and early 2023, not the entirety of next year, Lohr told analysts in a call.
The GMB union is calling for an immediate substantial increase in the hourly rate of pay for security staff at Leeds Bradford airport.
Peripheral Vascular Devices Market Research Report by Product (Angioplasty Balloons, Angioplasty Stents, and Balloon Inflation Devices), End Users, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) – Global Forecast to 2027 – Cumulative Impact of COVID-19New York, Aug. 10, 2022 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report "Peripheral Vascular Devices Market Research Report by Product, End Users, Region – Global Forecast to 2027 – Cumulative Impact of C
A London home now costs just over £526,000 on average. Here’s what half a million pounds could buy you across London right now. In London’s cheapest borough, this three-bedroom semi-detached house has a living area that leads to a long, narrow rear garden.
Learn how to add up to £60,000 to your home's value.